Citadel Advisors »

Akari Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Akari Therapeutics (AKTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Akari Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akari Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akari Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $103k 10k 10.25

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Akari Therapeutics

MMCAP International Inc. SPC
Cresset Asset Management
Jane Street
Hrt Financial
Citadel Advisors
IFP Advisors
SBI Securities
Caitong International Asset Management
Northwestern Mutual Wealth Management Company
Truvestments Capital
Morgan Stanley

View all funds holding Akari Therapeutics